Skip to main content
letter
. 2020 Dec 9;82(5):186–230. doi: 10.1016/j.jinf.2020.12.007

Fig. 1.

Fig. 1

Performance of Panbio COVID-19 antigen Rapid Test Device in nasal, saliva and nasal + saliva samples according to the presence of symptoms and cycle threshold values. A: Performance in nasal samples. B: Performance in saliva samples. C: Performance in nasal + saliva samples. D: Performance in symptomatic patients according to cycle threshold values and days from symptom onset.